Uncategorized
Pfizer’s Conditionally Approved Braftovi Combo Therapy Regime Shows Improved Response In Colorectal Cancer Patients
Pfizer’s Phase 3 BREAKWATER trial showed Braftovi combo improved response rates and duration in BRAF V600E-mutant metastatic colorectal cancer. read more
Traders Want The Fed To Tame Market Volatility, Yet Trump-Powell Interest Rate Fight Is Just Beginning
The Federal Reserve’s first meeting of 2025 comes at a moment of elevated uncertainty, as a brutal tech sell-off erased trillions in market value and fresh tensions between President Donald Trump and Fed Chair Jerome Powell may threaten to shake interest rate policy in the months ahead. read more
Tesla Analyst’s Top 5 Items To Watch In Q4 Earnings: Will Refreshed Model Y, New EVs Help Growth?
Tesla analyst Mark Delaney shares the top items investors should watch in Tesla’s fourth-quarter financial results and an early take on the Model Y refresh. Latest Ratings for TSLA Date Firm Action From To Feb 2022 Daiwa Capital Upgrades Neutral Outperform Feb 2022 Piper Sandler Maintains Overweight Jan 2022 Credit Suisse Upgrades Neutral Outperform View…
Homebuilders Brace For Tough 2025, Analyst Downgrades D.R. Horton And Smith Douglas Amid Market Pressures
D.R. Horton and Smith Douglas Homes downgraded by BofA Securities analyst due to tough outlook for homebuilder stocks, declining demand, and rising costs. Latest Ratings for DHI Date Firm Action From To Mar 2022 JP Morgan Maintains Overweight Feb 2022 Barclays Maintains Overweight Jan 2022 UBS Initiates Coverage On Buy View More Analyst Ratings for…
Coinbase’s Toshi Cat Coin Leaps Past Dogecoin, Shiba Inu With 200% Surge In One Week
Toshi (CRYPTO: TOSHI), a meme coin named after Coinbase co-founder Brian Armstrong, has outperformed meme coin heavyweights like Dogecoin (CRYPTO: DOGE) and Shiba Inu (CRYPTO: read more
Bloomin’ Brands Faces Near-Term Pressure, Analyst Highlights Peer Brinker’s Turnaround Roadmap
BofA Securities downgraded Bloomin’ Brands from Neutral to Underperform, cutting the price target to $13. The company has faced a consistent decline in transaction growth, particularly within its largest brand, Outback. Latest Ratings for BLMN Date Firm Action From To Feb 2022 Morgan Stanley Maintains Equal-Weight Feb 2022 Deutsche Bank Maintains Buy Feb 2022 BMO…
Kinross Gold’s Production Outlook Improves, Analyst Double Upgrades Stock
Kinross Gold receives a double upgrade to “Buy” with a price target of $12.75, as production forecasts rise to 2M GEOs annually. Barrick Gold, however, faces challenges with mine shutdowns and tax disputes, leading to a downgrade to “Neutral.” Analyst adjustments project Kinross boosting shareholder returns in 2025, while Barrick grapples with risks in Mali…
Why Is Allakos Stock Plunging On Monday?
Allakos halts AK006 development after phase 1 trial disappoints. Restructuring includes workforce cuts and $34 million-$38 million in estimated costs. read more
Bloomin Brands Stock: A Deep Dive Into Analyst Perspectives (7 Ratings)
Latest Ratings for BLMN Date Firm Action From To Feb 2022 Morgan Stanley Maintains Equal-Weight Feb 2022 Deutsche Bank Maintains Buy Feb 2022 BMO Capital Maintains Outperform View More Analyst Ratings for BLMN View the Latest Analyst Ratings read more